Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Cash and cash equivalents	$ 233,935	$ 66,533
Grants receivable	553,963	882,319
Prepaid expenses and other current assets	634,693	264,762
Total current assets	1,422,591	1,213,614
Property and equipment, net	739,606	753,376
Operating lease right-of-use assets, net	1,398,168	1,591,519
Total assets	3,560,365	3,558,509
LIABILITIES AND DEFICIT
Accounts payable	908,606	702,911
Operating lease liabilities – Current	223,761	224,988
SAFE Liability	1,000,000	1,000,000
Taxes payable		42,267
Total current liabilities	5,802,300	2,415,294
Deferred grant reimbursement	137,035	140,703
Operating lease liabilities	1,222,348	1,386,831
Total liabilities	7,161,683	3,942,828
Commitments and Contingencies
Deficit:
Preferred stock, $0.000001 par value, 5,000,000 shares authorized; no shares issued and outstanding on September 30, 2024 and December 31, 2023, respectively.
Common shares, 100,000,000 authorized shares at $0.000001; 6,252,349 and 6,250,002 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.	6	6
Additional paid-in-capital	6,508,660	5,700,298
Accumulated deficit	(10,109,984)	(6,084,623)
Total Deficit	(3,601,318)	(384,319)
Total liabilities and deficit	3,560,365	3,558,509
Nonrelated Party [Member]
LIABILITIES AND DEFICIT
Related party note	255,840	445,128
Related Party [Member]
LIABILITIES AND DEFICIT
Related party note	$ 3,414,093